TiO2/SiO2复合中空微球的选择性改性与药物缓释性能研究

doi:10.3724/SP.J.1077.2010.00201

摘要/Abstract

摘要：

以聚合物微球为模板, 通过溶胶凝胶法制备了 TiO₂/SiO₂复合中空微球, 并分别采用硬脂酸和无机磷酸对内层二氧化钛进行了疏水和亲水改性. 扫描电镜（SEM）和氮气吸附脱附结果表明中空微球具有完整的球形空腔和多孔的壳层孔道结构. 傅立叶红外光谱（FTIR）证实了内部疏水及亲水改性层的存在. 以布洛芬药物为对象, 采用热重分析（TGA）和高效液相色谱(HPLC）考察了不同改性对复合中空微球的载药量及缓释性能的影响. 研究结果表明, 由于存在疏水作用, 硬脂酸改性的中空微球载药量（189.8mg/g）高于未改性中空微球(177.5mg/g）, 且药物释放速率明显减慢, 53h 内药物释放率仅为 55％; 与此相反, 无机磷酸亲水改性的中空微球载药量减小（为 153.0mg/g）, 且释放速率提高, 10h 内释放了将近 80％的药物. 因此, 采用不同的改性基团可以对复合中空微球的药物释放速率进行有效地调控.

关键词: 复合中空微球, 药物缓释, 表面改性

Abstract:

The composite TiO₂/SiO₂ hollow spheres (CHSs) were successfully prepared via sol-gel process using carboxyl-functionalized polystyrene spheres as templates. Then the titania layer was selectively modified with stearic acid and phosphate, forming hydrophobic and hydrophilic interior, respectively. Their hollow and porous structures were confirmed by scanning electron microscope (SEM) and N₂ sorption analysis. Fourier transform infrared (FT-IR) spectra indicate that the interaction between the modifiers and the surface of titania is not physical adsorption but chemical combination. Using ibuprofen (IBU) as a model drug, the investigation of drug loading amounts and release rates shows that they can be regulated by suitable modification. Compare with the unmodified system, the stearic acid modified CHSs exhibit higher drug loading amount and lower release rate due to the hydrophobic effect. The IBU loading amount reaches 189.8mg/g and only about 55% of IBU is released within 53h. However, the phosphate modified CHSs exhibit relatively low drug loading amount (153.0mg/g) and high release rate, probably associated to the hydrophilic shells and charge repulsion. Its release percentage reaches nearly 80% within 10h. Therefore, the produced CHSs have potential application in the sustained drug delivery.

Key words: composite hollow spheres, controlled release, surface modification

中图分类号:

TB32

姚礼峰,石燕,温丽丽,沈强,张联盟. TiO₂/SiO₂复合中空微球的选择性改性与药物缓释性能研究[J]. 无机材料学报, DOI: 10.3724/SP.J.1077.2010.00201.

YAO Li-Feng,SHI Yan,WEN Li-Li,SHEN Qiang,ZHANG Lian-Meng. Selective Modification and Application for Controlled Release of TiO₂/SiO₂ Composite Hollow Spheres[J]. Journal of Inorganic Materials, DOI: 10.3724/SP.J.1077.2010.00201.

参考文献

［1］Im S H, Jeong U, Xia Y. Polymer hollow particles with controllable holes in their surfaces. Nature Materials, 2005, 4(9): 671-675.

［2］Wei W, Ma G H, Hu G, et al. Preparation of hierarchical hollow CaCO₃particles and the application as anticancer drug carrier. J. Am. Chem. Soc., 2008, 130(47): 15808-15810.

［3］Son S J, Bai X, Lee S B. Inorganic hollow nanoparticles and nanotubes in nanomedicine (Part 1): drug/gene delivery applications. Drug Discovery Today, 2007, 12(15/16): 650-656.

［4］Pei A H, Shen Z W, Yang G S. Preparation of TiO₂ nanocapsules for loading and release of antimicrobial triclosan molecules. Mater. Lett., 2007, 61(13): 2757-2760.

［5］Cao S W, Zhu Y J, Ma M Y, et al. Herarchically nanostructured magnetic hollow spheres of Fe₃O₄ and γ-Fe₂O₃: preparation and potential application in drug delivery. J. Phys. Chem. C, 2008, 112(6): 1851-1856.

［6］Zhu Y F, Shi J L, Li Y S, et al. Storage and release of ibuprofen drug molecules in hollow mesoporous silica spheres with modified pore surface. Microporous Mesoporous Mater., 2005, 85(1/2): 75-81.

［7］Zhu Y F, Shi J L. A mesoporous core-shell structure for pH-controlled storage and release of water-soluble drug. Microporous Mesoporous Mater., 2007, 103(1/2/3): 243-249.

［8］Wu X D, Wang D, Yang S R. Preparation and characterization of stearate-capped titanium dioxide nanoparticles. J. Colloid Interface Sci., 2000, 222(1): 37-40.

［9］Song Y Y, Bauer S, Schmuki P, et al. Amphiphillic TiO₂nanotube arrays: an actively controllable drug delivery system.J. Am. Chem. Soc., 2009, 131(12): 4230-4232.

［10］Gawalt E S, Avaltroni M J, Koch N, et al. Self-assembly and bonding of alkanephosphonic acids on the native oxide surface of titanium.Langmuir, 2001, 17(19): 5736-5738.

［11］Mitchell D T, Lee S B, Martin C R. Smart nanotubes for bioseparations and biocatalysis. J. Am. Chem. Soc., 2002, 124(40): 11864-11865.

［12］Son S J, Reichel J, Lee S B, et al. Magnetic nanotubes for magneticfield-assisted bioseparation, biointeraction, and drug delivery. J. Am. Chem. Soc., 2005, 127(20):7316-7317.

［13］Schafer W A, Carr P W. Chromatographic characterization of a phosphate-modified zirconia support for bio-chromatographic applications. J. Chromatogr., 1991, 587(22): 149-160.

[1]	蔡和庆, 韩璐, 杨松松, 薛新玉, 张扣, 孙志成, 刘儒平, 胡堃, 危岩. 小粒径Fe₃O₄-DMSA-PEI磁性纳米颗粒的制备及其基因负载能力研究[J]. 无机材料学报, 2024, 39(5): 517-524.
[2]	周港怀, 刘耀, 石原, 刘绍军. 活性氧化铝催化剂载体的光固化浆料制备与成型[J]. 无机材料学报, 2022, 37(3): 297-302.
[3]	董少杰,王旭东,沈国芳,王晓虹,林开利. 生物陶瓷支架的功能改性及应用研究进展[J]. 无机材料学报, 2020, 35(8): 867-881.
[4]	李昊耕,谷红宇,章俞之,宋力昕,吴岭南,齐振一,张涛. 聚合物材料表面原子氧防护技术的研究进展[J]. 无机材料学报, 2019, 34(7): 685-693.
[5]	施张宇, 李全, 唐颂超, 钱军, 潘泳康, 魏杰. 表面改性对介孔硅酸钙镁/聚醚醚酮复合材料性能的影响[J]. 无机材料学报, 2018, 33(1): 67-74.
[6]	陈宇方, 李宇杰, 郑春满, 谢凯, 陈重学. 富锂层状氧化物正极材料研究进展[J]. 无机材料学报, 2017, 32(8): 792-800.
[7]	余素春, 喻莹, 戴红莲. 明胶微球/磷酸镁基骨水泥复合药物缓释体系的构建[J]. 无机材料学报, 2017, 32(6): 655-660.
[8]	吕智慧, 洪天增, 乃学瑛, 董亚萍, 李武. 无水硫酸钙晶须的无机-有机表面改性机理研究[J]. 无机材料学报, 2017, 32(1): 81-85.
[9]	李磊, 张巧玲, 范红蕾, 刘有智, 魏冰, 冯玉杰. 水杨酸和精氨酸改性二氧化钛颗粒的制备及其在油-水界面的光催化反应[J]. 无机材料学报, 2016, 31(4): 413-420.
[10]	朱开平, 王德平, 范宏圆, 王会, 姚爱华, 叶松. 硼酸盐玻璃的原位转化及对浸泡液酸碱度的影响[J]. 无机材料学报, 2015, 30(10): 1069-1074.
[11]	蒋立新, 蒋柳云, 马驰, 韩崇涛, 徐莉娟, 熊成东. 新型改性的n-HA与PLGA复合材料的制备及性能研究[J]. 无机材料学报, 2013, 28(7): 751-756.
[12]	张翔, 周大利, 龙沁, 周加贝, 谭言飞, 柳淑婧. 磷灰石-硅灰石生物活性玻璃陶瓷表面接枝多肽改性研究[J]. 无机材料学报, 2013, 28(10): 1137-1142.
[13]	刘冠伟, 谢志鹏, 吴音. 液相前驱体浸渗技术调控陶瓷材料组成和特性的研究进展[J]. 无机材料学报, 2011, 26(11): 1121-1128.
[14]	贾忠琦, 李晓萱, 肖正辉, 王文平, 曹楠楠. 两亲性纳米SiO₂复合材料的合成[J]. 无机材料学报, 2011, 26(10): 1085-1089.
[15]	刘浩怀, 张建华, 许庆陵, 张利, 李玉宝. 包埋载药微球的羟基磷灰石/聚氨酯复合组织工程支架的研究[J]. 无机材料学报, 2011, 26(10): 1073-1077.

TiO₂/SiO₂复合中空微球的选择性改性与药物缓释性能研究

Selective Modification and Application for Controlled Release of TiO₂/SiO₂ Composite Hollow Spheres

PDF (PC)

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价